THE HUMAN BONE MARROW AS AN IMMUNOREGULATORY ORGAN1
THE REJECTION OF NEURAL XENOTRANSPLANTS: A ROLE FOR ANTIBODIES?
MAXIMIZING THE BENEFITS OF HLA MATCHING FOR RENAL TRANSPLANTATION: ALLELES, SPECIFICITIES, CREGS, EPITOPES, OR RESIDUES?
HEPATITIS C LINKS HEPATOLOGISTS, NEPHROLOGISTS AND TRANSPLANT SURGEONS
PERSISTENCE OF DONOR ANTIGEN IS NECESSARY FOR MAINTENANCE OF XENOTOLERANCE-A PARALLEL TO ALLOGENEIC SYSTEMS?
EVALUATION OF HLA MATCHING FOR CREG ANTIGENS IN EUROPE1
A PHASE I STUDY OF A 4-WEEK COURSE OF SDZ-RAD (RAD) IN QUIESCENT CYCLOSPORINE-PREDNISONE-TREATED RENAL TRANSPLANT RECIPIENTS1,2
OUTCOME OF TRANSPLANTATION OF ORGANS PROCURED FROM BACTEREMIC DONORS1
MINIMUM GRAFT SIZE FOR SUCCESSFUL LIVING DONOR LIVER TRANSPLANTATION
EVALUATION OF PRE- AND POSTTRANSPLANT DONOR-SPECIFIC TRANSFUSION/CYCLOSPORINE A IN NON-HLA IDENTICAL LIVING DONOR KIDNEY TRANSPLANT RECIPIENTS
CYTOMEGALOVIRUS PP65 ANTIGENEMIA MONITORING AS A GUIDE FOR PREEMPTIVE THERAPY: A COST EFFECTIVE STRATEGY FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN ADULT LIVER TRANSPLANT RECIPIENTS1
OUTCOME OF HEPATITIS C VIRUS-ASSOCIATED MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS AFTER LIVER TRANSPLANTATION
T CELL LYMPHOMA INVOLVING THE GRAFT OF A MULTIVISCERAL ORGAN RECIPIENT
LUNG PROCUREMENT BY LOW-POTASSIUM DEXTRAN AND THE EFFECT ON PRESERVATION INJURY
INTERCELLULAR ADHESION MOLECULE-1/LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN-1 BLOCKADE INHIBITS ALLOANTIGEN SPECIFIC HUMAN T CELL EFFECTOR FUNCTIONS WITHOUT INDUCING ANERGY1
DISCORDANT NEURAL TISSUE XENOGRAFTS SURVIVE LONGER IN IMMUNOGLOBULIN DEFICIENT MICE1
RECOGNITION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II ANTIGENS BY TWO ANTI-HLA-DR MONOCLONAL ANTIBODIES ON CANINE MARROW CELLS CORRELATES WITH EFFECTS ON IN VITRO AND IN VIVO HEMATOPOIESIS1
IN VITRO IMMUNOGENICITY OF CADAVER DONOR BONE MARROW CELLS USED FOR THE INDUCTION OF ALLOGRAFT ACCEPTANCE IN CLINICAL TRANSPLANTATION1
MAINTENANCE AND REVERSIBILITY OF NATURAL KILLER CELL- AND T CELL-INDEPENDENT B LYMPHOCYTE XENOTOLERANCE IN ATHYMIC NUDE RATS1,2,3
PRODUCTION OF HUMAN ALLOREACTIVE ANTIBODIES BY UREMIC SENSITIZED LYMPHOCYTES ENGRAFTED IN SEVERE COMBINED IMMUNODEFICIENT MICE
A PILOT STUDY OF IMMUNOSUPPRESSIVE MONOTHERAPY IN LIVER TRANSPLANTATION: TACROLIMUS VERSUS MICROEMULSIFIED CYCLOSPORIN
PORTAL VENOPLASTY FOR RECIPIENTS IN LIVING-RELATED LIVER TRANSPLANTATION1
FEATURES OF ACUTE REJECTION THAT INCREASE RISK FOR CHRONIC REJECTION1
CYTOMEGALOVIRUS INFECTION AND POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN RENAL TRANSPLANT RECIPIENTS: RESULTS OF THE U.S. MULTICENTER FK506 KIDNEY TRANSPLANT STUDY GROUP
LIVER TRANSPLANTATION IN POLYSPLENIA SYNDROME
CYCLOSPORINE AND TRIPLE-DRUG TREATMENT WITH HUMAN IMMUNODEFICIENCY VIRUS PROTEASE INHIBITORS
TRIMETAZIDINE COUNTERACTS TACROLIMUS NEPHROTOXICITY IN A HYPERTENSIVE LIVER TRANSPLANT PATIENT
ANNOUNCEMENTS